Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05953961 · ClinicalTrials.gov registry record · NA
90Y Transarterial Radioembolization Versus Microwave Ablation in Small Hepatocellular Carcinoma With Hypoalbuminemia
A NA study of Carcinoma, Hepatocellular, sponsored by Ochsner Health System.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT05953961 is a NA study of Carcinoma, Hepatocellular that is actively recruiting participants, run by Ochsner Health System. The registered enrollment target is 50 participants, below the 611-participant average among 27 other Carcinoma, Hepatocellular trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05953961, a NA study of Carcinoma, Hepatocellular, is actively recruiting participants, sponsored by Ochsner Health System.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This clinical trial will compare 1-year outcomes in patients with hypoalbuminemia and a new diagnosis of small, early-stage hepatocellular carcinoma (HCC) who are candidates for both 90-Yittrium Therasphere transarterial radioembolization (90Y) and microwave ablation (MWA). The study will determine whether treatment with 90Y lowers the risk of disease progression within the first year after diagnosis. Participants will be randomized to receive either first cycle 90Y or MWA and then proceed with standard of care.
Conditions Studied
Interventions
- DEVICE Therasphere 90Y
- DEVICE Microwave Ablation
Study Locations (1)
Louisiana
- Ochsner Main Campus - New Orleans
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2023-08-08 |
| Est. Completion | 2027-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05953961
The ClinicalTrials.gov registry entry for NCT05953961 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 611-participant average among 27 other Carcinoma, Hepatocellular trials with a reported enrollment target (92% lower). The listed sponsor is Ochsner Health System, which has 29 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Carcinoma, Hepatocellular appearing as the primary indexed condition, and to 2 interventions - of which Therasphere 90Y is the first listed.
NCT05953961 reports 1 study location spanning 1 distinct geographic area - top geographies include Louisiana.
Frequently Asked Questions
What is clinical trial NCT05953961 about?
NCT05953961 is a clinical study titled "90Y Transarterial Radioembolization Versus Microwave Ablation in Small Hepatocellular Carcinoma With Hypoalbuminemia". This clinical trial will compare 1-year outcomes in patients with hypoalbuminemia and a new diagnosis of small, early-stage hepatocellular carcinoma (HCC) who are candidates for both 90-Yittrium Therasphere transarterial radioembolization (90Y) and microwave ablation (MWA). The study will determine ...
What is the current status of trial NCT05953961?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2023-08-08. Estimated completion is 2027-01.
What conditions does trial NCT05953961 study?
This clinical trial studies the following conditions: Carcinoma, Hepatocellular.
What interventions are being tested in trial NCT05953961?
The interventions under investigation include: Therasphere 90Y (DEVICE), Microwave Ablation (DEVICE).
Who is sponsoring clinical trial NCT05953961?
This trial is sponsored by Ochsner Health System, which has 29 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05953961 being conducted?
This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Carcinoma, Hepatocellular
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
RECRUITING · NA
-
Advanced Image Guidance Utilized in Liver Surgery
COMPLETED · NA
-
Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma
RECRUITING
-
National Liver Cancer Screening Trial
RECRUITING · Phase 4
-
ABX196 in Combination With Nivolumab in Patients With Hepatocellular Carcinoma
RECRUITING · Phase 1
-
Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.